Amanote Research

Amanote Research

    RegisterSign In

Treatment of NMO

Clinical Neurology - Japan
doi 10.5692/clinicalneurol.49.902
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

January 1, 2009

Authors
Takahiko Saida
Publisher

Societas Neurologica Japonica


Related search

NMO-IgG-negative Relapsing Myelitis

Spinal Cord
MedicineNeurologyRehabilitation
2008English

Transient Hyperckemia in the Setting of Neuromyelitis Optica (NMO)

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2014English

High‐resolution AVO Analysis Before NMO

2003English

Relapsing Aqp4 Antibody Negative Nmo With Mog Antibodies

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2014English

DMO and NMO as Applied in Seismic Data Processing

Bulletin of the Geological Society of Malaysia
EarthPlanetary Sciences
1989English

Seroprevalence of NMO-IgG Antibody in Brazilian Patients With Neuromyelitis Optica

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2008English

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness

Journal of Immunology Research
MedicineAllergyImmunology
2018English

An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison With Cell-Based Assays

PLoS ONE
Multidisciplinary
2013English

Odd O in NMO: Isolated Horner Syndrome Without Optic Neuritis in a Patient With Neuromyelitis Optica

BMJ Case Reports
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy